A Study of KM602 in Patients With Advanced Solid Tumors

NCT05766527 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

BIOLOGICAL: KM602

Sponsor

Xuanzhu Biopharmaceutical Co., Ltd.